Navigation Links
Juventas Therapeutics Raises $22.2 Million Series B Financing
Date:7/16/2012

CLEVELAND, July 16, 2012 /PRNewswire/ -- Juventas Therapeutics, a clinical-stage regenerative medicine company, announced today that it has closed a $22.2 million Series B financing that was co-led by Triathlon Medical Venture Partners and New Science Ventures.  All previous venture firms, including Fletcher Spaght Ventures, Reservoir Venture Partners and Early Stage Partners participated in the round.  Also joining the syndicate are new investors Takeda Ventures, Venture Investors, Global Cardiovascular Innovation Center, Tri-State Growth Fund, Glengary and select angel investors. 

The proceeds will fund completion of ongoing Phase II clinical trials investigating the use of JVS-100 in treating patients with chronic heart failure or critical limb ischemia.  Both trials are actively enrolling patients.  JVS-100, the Company's lead product, encodes Stromal cell-Derived Factor 1 (SDF-1) which has been shown to repair damaged tissue through recruitment of circulating stem cells to the site of injury, prevent ongoing cell death and restore blood flow. 

"The funds raised through this Series B will carry us through significant clinical milestones," states Rahul Aras, Ph.D., President & CEO of Juventas Therapeutics.  "The fact that the round was oversubscribed and added several new investors to an already strong syndicate speaks to the excitement that is building around regenerative medicine, and specifically, the unique factor-based strategy employed by Juventas."

Clinical studies by several companies have demonstrated that delivery of adult stem cells to patients suffering from heart failure or critical limb ischemia has the potential to promote tissue repair and improve clinical outcomes.  In spite of these clinical findings, questions remain about the affordability and accessibility of cell-based therapy for the general population.  Rather than deliver cells, Juventas delivers JVS-100, whic
'/>"/>

SOURCE Juventas Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Silence Therapeutics Announces Subscription and Open Offer to Raise up to £5.7 Million
2. Nektar Therapeutics Announces Private Placement of $125 Million of Senior Secured Notes Due in 2017
3. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
4. Global Neuroendocrine Carcinoma Therapeutics Market To Reach $475m By 2019 - Report
5. United Therapeutics Announces Additional $100 Million Share Repurchase Program
6. Healthpoint Biotherapeutics To Create State-of-the-Art Cell Sciences Manufacturing Facility
7. ResearchMoz: Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar- Market Research Report
8. Study of Cell Therapeutics Tosedostat for Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Now Enrolling
9. Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
10. Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
11. Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... On August 4, 2015, the White House will ... from across the United States to talk about their experiences with innovation and present ... to be among the attendees. , One of the day’s aims is to grow ...
(Date:8/4/2015)... LOS ANGELES , Aug. 4, 2015   ... announced the recent acquisition of LifeLine Cryogenics, an east ... the New York tristate area. ... tissues, and all prepaid contracts will be honored. ... of cryogenics services, offering storage of sperm, eggs, embryos, ...
(Date:8/4/2015)... 4, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ... China , today announced that it will ... ended June 30, 2015, after market close on Wednesday, ... on Thursday, August 13, 2015, at 8:00 a.m. EDT ... Time) to review the Company,s financial results and provide ...
(Date:8/3/2015)... 2015  Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... second quarter 2015 on Monday, August 10, 2015 at ... , president and chief executive officer, will lead the ... financial results for the second quarter 2015. ... section of Halozyme,s corporate website and a recording will ...
Breaking Biology Technology:White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2FamilyCord Announces Acquisition of LifeLine Cryogenics 2Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results 2Halozyme to Host Second Quarter 2015 Financial Results Conference Call 2
... - The June 30 deadline is approaching for ... $223.9 million in benefits from a class action ... attorneys lawyers involved in the court-approved settlement. ... Wisconsin's antitrust and unfair competition laws. , ,The ...
... - Abandoned and failed information technology programs have cost state ... trend that has some members of the Legislature wondering if ... reprogram the whole mess. , ,There's probably no need to ... government's cut-and-paste IT operations. Instead, lawmakers should look for best ...
... - Since it was founded in 1998, EMSystem ... of web-based communications and resource management for hospitals and emergency ... attained that stature or gotten off the ground at all ... is, in the words of one of its founders, one ...
Cached Biology Technology:June 30 is deadline to claim up to $223.9M in Microsoft settlement 2Ethics Board site offers welcome contrast to state IT mistakes 2Ethics Board site offers welcome contrast to state IT mistakes 3Pre-eminent, web-based companies owe success to corporate venturing 2Pre-eminent, web-based companies owe success to corporate venturing 3Pre-eminent, web-based companies owe success to corporate venturing 4Pre-eminent, web-based companies owe success to corporate venturing 5Pre-eminent, web-based companies owe success to corporate venturing 6
(Date:8/3/2015)... , Aug. 3, 2015 Synaptics, Inc. (Nasdaq: ... solutions, today announced that members of the executive management ... Pacific Crest Global Technology Leadership Forum on Tuesday, August ... will be held at the Sonnenalp Resort in ... presentation may include forward-looking information. An audio webcast of ...
(Date:7/31/2015)... Kina, 31. juli 2015 Den 10. internationale ... af BGI fra den 22. - 25. oktober i ... fejrer sin 10-års fødselsdag i år. Siden starten i ... årlige møder på ,omik,-feltet, og er en af de ... ICG-10 fokuserer på nylige gennembrud og fremskridt inden ...
(Date:7/31/2015)... 31 de julio de 2015 BGI llevará a ... ) del 22 al 25 de octubre de 2015, ... La conferencia celebra su décimo aniversario este año. Desde ... una de las reuniones anuales más influyentes del mundo ... de las conferencias científicas más dinámicas, entusiastas y amenas. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... A new research study at the University of Delaware ... microorganism that lives in seawater and is related to ... and virulence. V. parahaemolyticus is a ... with the consumption of raw or undercooked seafood, particularly ...
... dogs in western and central Africa comes from a ... ago, probably by European colonialists. In the current issue ... of scientists from Africa, USA and France report that ... country level and that there is only limited movement ...
... beneficial effect of anakinra for rheumatoid arthritis patients, but ... use with other biologic medications. Rheumatoid arthritis is ... in 100 people worldwide. It affects the joints, making ... new breed of arthritis drugs licensed in the past ...
Cached Biology News:UD research study to shed light on emerging seaborne pathogen 2UD research study to shed light on emerging seaborne pathogen 3Hope for a rabies eradication strategy in Africa 2Anakinra for rheumatoid arthritis: A modest benefit with some risk 2
Cells are grown in triple flasks or roller bottles. Viability and growth data are generated from a parallel representative culture....
... Agencourt offers SNP loci identification through ... automated assay design, intensive assay validation/optimization, ... of Corriell or customer-supplied samples and ... service provides for rapid and highly ...
... Agencourt offers pre-validated SNP ... 1500 amplicons within 93 ... kinases, and more than ... These assays were developed ...
... aqueous-based mounting medium designed for the ... is especially recommended when using tracers ... It can also be used with ... (FITC), Rhodamine (TMRITC) and Texas Red. ...
Biology Products: